Zymeworks
Utility Patent Applications
Last updated:
List of all Zymeworks patents 30 in total
Status | Patent |
---|---|
Application | Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: MODIFIED ANTIGEN BINDING POLYPEPTIDE CONSTRUCTS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ENGINEERED IMMUNOGLOBULIN HEAVY CHAIN-LIGHT CHAIN PAIRS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 FOR THE TREATMENT OF BILIARY TRACT CANCERS Filling date: 26 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: Antigen-Binding Constructs Targeting HER2 Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES Filling date: 26 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: Antigen-Binding Polypeptide Constructs Comprising Kappa and Lambda Light Chains and Uses Thereof Filling date: 26 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: Engineered Immunoglobulin Heavy Chain-Light Chain Pairs and Uses Thereof Filling date: 26 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: METHODS USING MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 IN COMBINATION WITH CDK4/6 INHIBITORS FOR THE TREATMENT OF BREAST CANCER Filling date: 26 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS Filling date: 26 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: STABILIZED CHIMERIC FABS Filling date: 26 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME Filling date: 26 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN Filling date: 26 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: TUMOR ANTIGEN PRESENTATION INDUCER CONSTRUCTS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS Filling date: 26 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME Filling date: 26 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Antigen-Binding Polypeptide Constructs Comprising Kappa and Lambda Light Chains and Uses Thereof Filling date: 26 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES Filling date: 26 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs Filling date: 26 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES Filling date: 26 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 30 of 30 patents.